Jessalyn Holodinsky, PhD

Jessalyn Holodinsky, PhD, has a diverse work experience in the field of research and academia. Jessalyn started their career as a Postdoctoral Researcher at the University of Calgary in July 2015, where they worked with Dr. Michael D. Hill on various projects related to stroke patients treated with endovascular therapy and prehospital transportation protocols for acute stroke. Jessalyn continued their research work at the University until the present time. In addition to their research role, they also served as a Sessional Instructor at the University from January 2018 to April 2021, demonstrating their teaching abilities.

In 2018, Dr. Holodinsky joined DESTINE Health as the CEO & Chief Science Officer, where they played a key leadership role in overseeing the company's scientific development. Jessalyn was involved in strategic decision-making and contributed to the growth of the company. Prior to their CEO position, they served as the Chief Science Officer and later moved on to be the CEO & Chief Scientific Officer (Co-Founder).

In 2019, Dr. Holodinsky joined the Sunnybrook Research Institute as a Postdoctoral Research Fellow, where they worked until June 2020. Their specific research focus during this time is not provided.

Overall, Dr. Jessalyn Holodinsky's work experience showcases their expertise in stroke research, prehospital transportation protocols, and leadership in the healthcare industry.

Jessalyn Holodinsky, PhD, has an extensive education history. Jessalyn completed their Bachelor's of Kinesiology (BKin) degree at the University of Calgary from 2008 to 2012. Following this, they pursued a Master of Science (MSc) degree in Health Services Research - Community Health Sciences at the same institution from 2012 to 2015. Continuing their academic journey, they obtained a Doctor of Philosophy (PhD) degree in Epidemiology - Community Health Sciences from the University of Calgary, completing it between 2015 and 2019.